Image
|
Figure Caption
Fig. 8 Effects of combined cytarabine and SHK treatment on Kasumi-1 cells. (A) Cells were treated with vehicle or cytarabine (2.5?40 ?M) for 48 h, and cell viability was determined by MTT assay. (B) Kasumi-1 cells were co-treated with cytarabine (5 ?M) and SHK (0.2 or 0.4 ?M) for 48 h, and cell viability was determined by MTT assay. Data represent the mean ± SD of three independent experiments. **p < 0.01 indicates significant differences compared to the vehicle alone-treated group. ##p < 0.01 indicates significant differences compared to the cytarabine alone- or SHK alone-treated group.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Biomed. Pharmacother.